(Press-News.org) A new study demonstrated parity between a minimally invasive procedure to replace the aortic valve in the heart—transcatheter aortic valve replacement (TAVR)—and surgical aortic valve replacement (SAVR).
In the meta-analysis of seven randomized trials, published in JSCAI and presented at the 2024 EuroPCR conference in Paris, France, researchers compared the outcomes of 7,785 patients undergoing TAVR (a procedure that delivers a new aortic valve into the heart through a catheter) to those undergoing SAVR for severe aortic stenosis. The study found no significant difference in death or disabling stroke between TAVR and SAVR patients (HR 1.02, 95% CI 0.93–1.11, p=0.70) with similar long-term mortality risks.
“This study represents the largest scale analysis so far available comparing longer-term percutaneous devices for aortic valve replacement versus surgery,” said study coauthor Eliano Pio Navarese, MD, PhD, head of clinical experimental cardiology and associate professor at the University of Sassari in Italy. “Our findings support the comparable long-term safety and efficacy of TAVR, as well as raise important considerations for valve type selection, particularly when we are dealing with longer-term valve durability and pacemaker implantation.”
The results were consistent across different surgical risk profiles (low, intermediate, and high). Compared with SAVR, TAVR was associated with an increased likelihood of needing a pacemaker and moderate-to-severe paravalvular leaks.
Notably, on a prespecified analysis, the study addressed the outcomes of two distinct TAVR devices versus SAVR. Compared with SAVR, self-expanding TAVR prostheses demonstrated lower death or stroke risk (P=0.06), valve thrombosis (P= 0.06), and valve gradients (P<0.01) but higher pacemaker implantation rates (P < 0.01) than balloon-expandable TAVR, highlighting potential long-term differences between the two percutaneous TAVR devices.
[ARTICLE LINK to go live at embargo lift: https://doi.org/10.1016/j.jscai.2024.102143]
###
About Society for Cardiovascular Angiography & Interventions (SCAI)
The Society for Cardiovascular Angiography & Interventions, established in 1978, stands as the primary nonprofit medical society dedicated to representing invasive and interventional cardiology. SCAI's mission is to guide the global interventional cardiovascular community by fostering education, advocacy, research, and upholding standards for quality patient care. For more than 40 years, SCAI has exemplified professional excellence and innovation worldwide, cultivating a reputable community of over 4,500 members committed to advancing medical science and providing life-saving care for individuals, both adults and children, affected by cardiovascular disease. For more information, visit https://scai.org/.
END
Transcatheter valve replacement outcomes similar to surgery
Largest scale analysis comparing longer-term percutaneous devices for aortic valve replacement versus surgery
2024-05-15
ELSE PRESS RELEASES FROM THIS DATE:
Germline regulation and sex differences: How they impact lifespan in vertebrates
2024-05-15
The study revealed unexpected and sex-specific effects of germline regulation on longevity and somatic repair in vertebrates. Contrary to classical evolutionary theories, it turns out that changing how the germline (the part responsible for reproduction) works can have different effects on males and females. This challenges conventional beliefs that reproduction and longevity are linked by a limited pool of resources. The research opens up new possibilities for understanding how our bodies age and the role of reproduction in that process. The findings ...
Detection of an Earth-sized exoplanet orbiting the ultracool dwarf star SPECULOOS-3
2024-05-15
The SPECULOOS project, led by the astronomer Michaël Gillon from the University of Liège, has just discovered a new Earth-sized exoplanet around SPECULOOS-3, an "ultracool dwarf" star as small as Jupiter, twice as cold as our Sun, and located 55 light-years from Earth. After the famous TRAPPIST-1, SPECULOOS 3 is the second planetary system discovered around this type of star.
Ultra-cool dwarf stars are the least massive stars in our Universe, similar in size to Jupiter, more than twice as cold, ten times less massive and a hundred times less ...
Scientists discover blood proteins that may give cancer warning 7 years before diagnosis
2024-05-15
Two Cancer Research UK-funded studies from Oxford Population Health have discovered proteins in the blood that could warn people of cancer more than seven years before it is diagnosed.
Scientists identified 618 proteins linked to 19 different types of cancer, including 107 proteins in a group of people who blood was collected at least seven years before diagnosis.
The team have discovered that these proteins could be involved at the very earliest stages of cancer, where it could be prevented.
They ...
Astronomers discover new Earth-sized world orbiting an ultra-cool star
2024-05-15
A new, Earth-sized planet orbiting an ultra-cool red dwarf star, has been detected by an international team of astronomers – just 55 light years away.
The planet is only the second of its kind to be discovered around this type of star. Called SPECULOOS-3 b, it takes around 17 hours to complete an orbit of the star which is more than twice as cold as our sun, as well as ten times less massive and a hundred times less luminous.
Days and nights on SPECULOOS-3 b seem to be endless: the planet is likely to be tidally locked, so the same side – the ‘dayside’ – always faces the star in a relationship similar to our moon and Earth.
The ...
New biomarker to diagnose Alzheimer's in asymptomatic stages
2024-05-15
A recent study led by the Molecular and Cellular Neurobiotechnology group at the Institute for Bioengineering of Catalonia (IBEC) and the University of Barcelona has identified a new biomarker for Alzheimer's disease in asymptomatic stages of the disease. The molecule is miR-519a-3p, a microRNA directly linked to the expression of the cellular prion protein (PrPC), which is deregulated in people suffering from some neurodegenerative diseases such as Alzheimer's.
The search for biomarkers that are stable and easily detectable in biofluids, ...
Research sheds light on how proteins linked to Alzheimer’s disease influence neuronal growth
2024-05-15
New research has shed light in the complex interplay between cell proteins, and how they impact on neurons in neurodevelopmental disorders and Alzheimer’s disease.
A new study led by the University of Exeter and published in Royal Society Open Biology has discovered the key role that the protein Contactin-4 (encoded by the gene CNTN4) plays in shaping neurons.
The researchers began studying CNTN4 because it was known to have a role in autism, but its functional roles were not well understood. The team explored how CNTN4 functions within the brain, particularly its interactions with proteins involved in neurodegenerative diseases like Alzheimer's ...
Early retirement of old vehicles won't save the planet: A study
2024-05-15
Lifespan caps for passenger vehicles have limited effect on reducing greenhouse gas emissions and could drive up costs and material use finds a new study published in Environmental Research: Infrastructure and Sustainability. The research shows that although Light-Duty vehicles (LDVs) contribute 17% to the annual greenhouse gas emissions in the United States, imposing a 15-year lifespan cap on LDV fleets under a business-as-usual scenario will not lead to any meaningful reductions in GHG emissions.
To combat delayed uptake of Electric Vehicles (EVs), some have argued for limits on the vehicle’s ...
EuroPCR 2024 – Short-term data from NOTION-2: TAVR versus SAVI for younger patients with aortic stenosis
2024-05-15
Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that will be presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical practice. Among them is the NOTION-2 randomised clinical trial (RCT).
Background
Evidence comparing the use of transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR) in low-risk patients with aortic ...
EuroPCR 2024 – One-month DAPT followed by 5-month Ticagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II
2024-05-15
Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that will be presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical practice. Among them is the REC-CAGEFREE II trial.
Background and methods
The REC-CAGEFREE II trial is an open-label, investigator-initiated, non-inferiority, multicentre randomised trial comparing stepwise de-escalation of dual antiplatelet therapy (DAPT) with standard DAPT in patients with acute coronary syndrome (ACS) treated with paclitaxel-coated balloons (PCB). Eligible ...
EuroPCR 2024 – Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial
2024-05-15
Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that will be presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical practice. Among them is the LANDMARK trial.
Background and Methods
Key randomized controlled trials have compared surgical aortic valve replacement (SAVR) with transcatheter aortic valve implantation (TAVI) using one of two commercially available transcatheter heart valves (THVs) - ...
LAST 30 PRESS RELEASES:
Toxic metals linked to impaired growth in infants in Guatemala
Being consistently physically active in adulthood linked to 30–40% lower risk of death
Nerve pain drug gabapentin linked to increased dementia, cognitive impairment risks
Children’s social care involvement common to nearly third of UK mums who died during perinatal period
‘Support, not judgement’: Study explores links between children’s social care involvement and maternal deaths
Ethnic minority and poorer children more likely to die in intensive care
Major progress in fertility preservation after treatment for cancer of the lymphatic system
Fewer complications after additional ultrasound in pregnant women who feel less fetal movement
Environmental impact of common pesticides seriously underestimated
The Milky Way could be teeming with more satellite galaxies than previously thought
New study reveals surprising reproductive secrets of a cricket-hunting parasitoid fly
Media Tip Sheet: Symposia at ESA2025
NSF CAREER Award will power UVA engineer’s research to improve drug purification
Tiny parasitoid flies show how early-life competition shapes adult success
New coating for glass promises energy-saving windows
Green spaces boost children’s cognitive skills and strengthen family well-being
Ancient trees dying faster than expected in Eastern Oregon
Study findings help hone precision of proven CVD risk tool
Most patients with advanced melanoma who received pre-surgical immunotherapy remain alive and disease free four years later
Introducing BioEmu: A generative AI Model that enables high-speed and accurate prediction of protein structural ensembles
Replacing mutated microglia with healthy microglia halts progression of genetic neurological disease in mice and humans
New research shows how tropical plants manage rival insect tenants by giving them separate ‘flats’
Condo-style living helps keep the peace inside these ant plants
Climate change action could dramatically limit rising UK heatwave deaths
Annual heat-related deaths projected to increase significantly due to climate and population change
Researchers discover new way cells protect themselves from damage
Rivers choose their path based on erosion — a discovery that could transform flood planning and restoration
New discovery reveals dopamine operates with surgical precision, not as a broad signal
New AI tool gives a helping hand to x ray diagnosis
New Leicester study reveals hidden heart risks in women with Type 2 Diabetes
[Press-News.org] Transcatheter valve replacement outcomes similar to surgeryLargest scale analysis comparing longer-term percutaneous devices for aortic valve replacement versus surgery